The adverse effect of a lack of lower limb/gluteofemoral fat on metabolism is strikingly apparent in patients with familial partial lipodystrophy, particularly types 2 and 3, due to specific mutations in LMNA and PPARG, respectively (39). The gene discussed is LMNA; the disease is familial partial lipodystrophy.